{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T10:07:00Z","timestamp":1781086020040,"version":"3.54.1"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Vasculitic neuropathies usually present acutely to subacutely, with an asymmetric pattern, involving multiple peripheral nerve territories. Drug-induced vasculitis is an often overlooked etiology of vasculitic neuropathy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>We present the first reported case of nitrofurantoin-associated and an illustrative case of minocycline-associated vasculitic neuropathy, with a review of the literature.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>The first patient is a 60-year-old woman who developed axonal sensorimotor peripheral neuropathy after nitrofurantoin use, with a superficial radial nerve biopsy confirming vasculitis. The second patient is a 23-year-old woman, with a history of acne vulgaris treated with minocycline, who presented with a subacute right common peroneal mononeuropathy followed by a left deep peroneal mononeuropathy, with elevated antinuclear, perinuclear-antineutrophil cytoplasmic, and myleoperoxidase antibodies, and MPO titers, and a sural nerve biopsy showing large arteriole vasculitis. Finally, we provide a comprehensive review of previously published cases.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Medications should be considered as a trigger for medication-induced vasculitic neuropathy. Accurate diagnosis would ensure timely treatment.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/cnd.0000000000000404","type":"journal-article","created":{"date-parts":[[2022,11,21]],"date-time":"2022-11-21T16:05:25Z","timestamp":1669046725000},"page":"85-94","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Nitrofurantoin and Minocycline\u2013Associated Vasculitic Neuropathy: Case Reports and Literature Review"],"prefix":"10.1097","volume":"24","author":[{"given":"Mohammad","family":"Aladawi","sequence":"first","affiliation":[{"name":"Departement of Neurological Sciences, University of Nebraska Medical Center, Omaha, NE;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahar","family":"Shelly","sequence":"additional","affiliation":[{"name":"Department of Neurology, Mayo Clinic, Rochester, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. James B.","family":"Dyck","sequence":"additional","affiliation":[{"name":"Department of Neurology, Mayo Clinic, Rochester, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Koster","sequence":"additional","affiliation":[{"name":"Deparmtent of Internal Medicine, Division of Rheumatology, Mayo Clinic, Rochester, MN; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JaNean","family":"Engelstad","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezequiel A.","family":"Piccione","sequence":"additional","affiliation":[{"name":"Departement of Neurological Sciences, University of Nebraska Medical Center, Omaha, NE;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elie","family":"Naddaf","sequence":"additional","affiliation":[{"name":"Department of Neurology, Mayo Clinic, Rochester, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250507","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1474-4422(13)70236-9","article-title":"Vasculitic neuropathies","volume":"13","author":"Gwathmey","year":"2014","journal-title":"Lancet Neurol."},{"key":"R2-20250507","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1212\/01.WNL.0000082715.48844.3E","article-title":"Nonsystemic vasculitic neuropathy","volume":"61","author":"Collins","year":"2003","journal-title":"Neurology"},{"key":"R3-20250507","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s11940-015-0374-1","article-title":"Vasculitic Neuropathies","volume":"17","author":"Naddaf","year":"2015","journal-title":"Curr Treat Options Neurol."},{"key":"R4-20250507","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/mus.24494","article-title":"Asymptomatic vasculitic neuropathy","volume":"52","author":"Kurt","year":"2015","journal-title":"Muscle Nerve"},{"key":"R6-20250507","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"Revised international chapel Hill consensus conference nomenclature of vasculitides","volume":"65","author":"Jennette","journal-title":"Arthritis Rheum."},{"key":"R7-20250507","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1136\/ard.2006.054593","article-title":"Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies","volume":"66","author":"Watts","year":"2007","journal-title":"Ann Rheum Dis."},{"key":"R8-20250507","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1212\/WNL.23.5.554","article-title":"Nitrofurantoin polyneuropathy","volume":"23","author":"Toole","year":"1973","journal-title":"Neurology"},{"key":"R9-20250507","first-page":"400","article-title":"Nitrofurantoin neuropathy. Australian and New Zealand","volume":"11","author":"Yiannikas","year":"1981","journal-title":"J Med."},{"key":"R10-20250507","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/0002-9343(71)90268-3","article-title":"Neural, hematologic and bacteriologic effects of nitrofurantoin in renal insufficiency","volume":"51","author":"Felts","year":"1971","journal-title":"Am J Med."},{"key":"R11-20250507","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1136\/bmj.1.6164.663","article-title":"Drug-induced peripheral neuropathies","volume":"1","author":"Argov","year":"1979","journal-title":"Br Med J."},{"key":"R12-20250507","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1001\/archinte.1984.00350160187030","article-title":"Nitrofurantoin unmasking peripheral neuropathy in a type 2 diabetic patient","volume":"144","author":"White","year":"1984","journal-title":"Arch Intern Med."},{"key":"R13-20250507","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1136\/jnnp.29.3.224","article-title":"Nitrofurantoin and peripheral neuropathy with megaloblastic anaemia","volume":"29","author":"Morris","year":"1966","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R14-20250507","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1001\/archneurol.2011.1120","article-title":"Peripheral nerve toxic effects of nitrofurantoin","volume":"69","author":"Tan","year":"2012","journal-title":"Arch Neurol."},{"key":"R15-20250507","first-page":"41","article-title":"Nitrofurantoin-induced acute, subacute and chronic pulmonary reactions","volume":"58","author":"Sovij\u00e4rvi","year":"1977","journal-title":"Scand J Respir Dis."},{"key":"R16-20250507","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/j.1699-0463.1977.tb00463.x","article-title":"Nitrofurantoin\u2010induced alterations in pulmonary tissue: a report on five patients with acute or subacute reactions","volume":"85","author":"Taskinen","year":"1977","journal-title":"Acta Pathologica Microbiologica Scand Section A Pathol."},{"key":"R17-20250507","first-page":"25","article-title":"Pulmonary vasculitis in a patient taking nitrofurantoin","volume":"74","author":"Oxenhandler","year":"1977","journal-title":"Case Report MO Med."},{"key":"R18-20250507","doi-asserted-by":"crossref","first-page":"bcr2014209253","DOI":"10.1136\/bcr-2014-209253","article-title":"Rare adverse effect of a common drug: nitrofurantoin-induced ANCA-associated vasculitis","volume":"2015","author":"Agarwal","year":"2015","journal-title":"BMJ Case Rep."},{"key":"R19-20250507","doi-asserted-by":"crossref","first-page":"e688","DOI":"10.1097\/MJT.0000000000001049","article-title":"Nitrofurantoin induced antineutrophil cytoplasmic antibodies-associated vasculitis","volume":"27","author":"Ubaid","year":"2020","journal-title":"Am J Ther."},{"key":"R20-20250507","first-page":"184","article-title":"Nitrofurantoin-induced chronic active hepatitis","volume":"4","author":"Amit","year":"2002","journal-title":"IMAJ-RAMAT GAN"},{"key":"R21-20250507","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/WNO.0000000000000743","article-title":"Minocycline-induced vasculitis presenting as a third nerve palsy","volume":"39","author":"Starr","year":"2019","journal-title":"J Neuroophthalmology"},{"key":"R22-20250507","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1212\/NXI.0000000000000007","article-title":"Minocycline-associated vasculitis of extracranial branches of vertebral arteries presenting as myelopathy","volume":"1","author":"Garg","year":"2014","journal-title":"Neurol Neuroimmunology Neuroinflammation"},{"key":"R23-20250507","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.semarthrit.2012.03.006","article-title":"Polyarteritis nodosa-like vasculitis in association with minocycline use: a single-center case series","volume":"42","author":"Kermani","year":"2012","journal-title":"Semin Arthritis Rheum."},{"key":"R24-20250507","doi-asserted-by":"crossref","first-page":"e180","DOI":"10.1212\/NXI.0000000000000180","article-title":"Vasculitic neuropathy following exposure to minocycline","volume":"3","author":"Baratta","year":"2016","journal-title":"Neurol Neuroimmunology Neuroinflammation."},{"key":"R25-20250507","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/CND.0b013e3181ee155d","article-title":"Vasculitic neuropathy associated with minocycline use","volume":"12","author":"Thaisetthawatkul","year":"2011","journal-title":"J Clin Neuromuscul Dis."},{"key":"R26-20250507","doi-asserted-by":"crossref","first-page":"301","DOI":"10.5692\/clinicalneurol.50.301","article-title":"Case of minocycline-induced vasculitic neuropathy","volume":"50","author":"Ogawa","year":"2010","journal-title":"Rinsho Shinkeigaku"},{"key":"R27-20250507","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/CND.0000000000000197","article-title":"Peripheral vasculitic neuropathy associated with minocycline use","volume":"19","author":"Kang","year":"2018","journal-title":"J Clin Neuromuscul Dis."},{"key":"R28-20250507","first-page":"S219","article-title":"Poster 391 beauty isn't necessarily benign: minocycline\u2010induced vasculitic neuropathy with central and peripheral involvement\u2013A case report","volume":"7","author":"Conlee","year":"2015","journal-title":"PMR."},{"key":"R29-20250507","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s10067-014-2831-8","article-title":"Primary and secondary central nervous system vasculitis: clinical manifestations, laboratory findings, neuroimaging, and treatment analysis","volume":"34","author":"Vera-Lastra","year":"2015","journal-title":"Clin Rheumatol."},{"key":"R30-20250507","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0049-0172(98)80035-8","article-title":"Coexistent minocycline-induced systemic lupuserythematosus and autoimmune hepatitis","volume":"28","author":"Angulo","year":"1998","journal-title":"Semin Arthritis Rheum."},{"key":"R31-20250507","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1111\/j.1365-2133.2007.07828.x","article-title":"Is minocycline therapy in acne associated with antineutrophil cytoplasmic antibody positivity? A cross\u2010sectional study","volume":"156","author":"Marzo\u2010Ortega","year":"2007","journal-title":"Br J Dermatol."},{"key":"R32-20250507","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S0002-9343(98)00325-8","article-title":"Clinical and immunological study of 7 patients with minocycline-induced autoimmune phenomena","volume":"105","author":"Elkayam","year":"1998","journal-title":"Am J Med."},{"key":"R33-20250507","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1126\/science.7973636","article-title":"Transformation of lupus-inducing drugs to cytotoxic products by activated neutrophils","volume":"266","author":"Jiang","year":"1994","journal-title":"Science"},{"key":"R34-20250507","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3109\/03602539208996297","article-title":"The role of leukocyte-generated reactive metabolites in the pathogenesis of ideosyncratic drug reactions","volume":"24","author":"Uetrecht","year":"1992","journal-title":"Drug Metab Rev."},{"key":"R35-20250507","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1080\/24725625.2020.1738983","article-title":"Contribution of HLA-DRB1* 09: 01 allele to development of minocycline induced antineutrophil cytoplasmic antibody (ANCA)-associated cutaneous vasculitis: report of two cases","volume":"4","author":"Kawahara","year":"2020","journal-title":"Mod Rheumatol Case Rep."},{"key":"R36-20250507","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1440-1797.2009.01100.x","article-title":"Review article: drug-induced anti-neutrophil cytoplasmic antibody-associated vasculitis","volume":"14","author":"Gao","year":"2009","journal-title":"Nephrology"},{"key":"R37-20250507","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1529-8027.2010.00281.x","article-title":"Peripheral Nerve Society Guideline* on the classification, diagnosis, investigation, and immunosuppressive therapy of non\u2010systemic vasculitic neuropathy: executive summary","volume":"15","author":"Collins","year":"2010","journal-title":"J Peripher nervous Syst."},{"key":"R38-20250507","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa0909169","article-title":"Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis","volume":"363","author":"Jones","year":"2010","journal-title":"N Engl J Med."},{"key":"R39-20250507","first-page":"41","article-title":"Treatment of vasculitic peripheral neuropathy: a retrospective analysis of outcome","volume":"100","author":"Mathew","year":"2007","journal-title":"J Assoc Physicians"},{"key":"R40-20250507","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S1474-4422(05)70249-0","article-title":"An update on the classification and treatment of vasculitic neuropathy","volume":"4","author":"Schaublin","year":"2005","journal-title":"Lancet Neurol."},{"key":"R41-20250507","doi-asserted-by":"crossref","first-page":"E33","DOI":"10.1002\/mus.25718","article-title":"Mononeuritis multiplex associated with minocycline in an adolescent","volume":"56","author":"McMillan","year":"2017","journal-title":"Muscle Nerve"}],"container-title":["Journal of Clinical Neuromuscular Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CND.0000000000000404","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T21:04:12Z","timestamp":1746651852000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CND.0000000000000404"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/cnd.0000000000000404","relation":{},"ISSN":["1522-0443"],"issn-type":[{"value":"1522-0443","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]}}}